Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116844
Status:
COMPLETED
Last Update Posted:
2018-02-12
First Post:
2005-06-30
Brief Title:
VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 HSV-2 Seropositive Subjects VALTREX Tablet is a Trademark of GlaxoSmithKline Group of Companies
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2006-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-30
First Submit QC Date:
June 30 2005
Study First Post Date:
2005-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-02-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-02
Last Update Post Date:
2018-02-12
Last Update Post Date Type:
ACTUAL